Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cgamma1.

The Journal of Biological Chemistry
M RoghaniD Moscatelli

Abstract

The roles of heparan sulfate proteoglycans and tyrosine kinase fibroblast growth factor (FGF) receptors in mediating the induction of plasminogen activator (PA) by FGF-2 were investigated using L6 myoblast cells that normally do not express detectable FGF receptors. PA was induced by FGF-2 in a dose-dependent manner in L6 cells expressing transfected FGF receptor-1 but not in nontransfected cells or cells transfected with the vector alone. The PA produced in these cells was characterized as urokinase-type PA (uPA). Thus, expression of a tyrosine kinase FGF receptor was required for induction of uPA. Internalization of FGF through heparan sulfates does not seem to be involved in this response as soluble heparin and suramin at concentrations which inhibited FGF-2 binding to heparan sulfates but not receptors did not affect the induction of uPA by FGF-2. Mutant receptors in which the tyrosine kinase was inactivated were not able to respond to FGF-2. In contrast, mutation of the site of phospholipase Cgamma1 (PLCgamma) binding in the receptor, which causes loss of PLCgamma activation, had no effect on uPA induction by FGF-2. These results suggest that PLCgamma activation is not required for induction of uPA by FGF-2.

References

Jan 1, 1992·Advances in Cancer Research·C Basilico, D Moscatelli
Dec 1, 1992·Molecular and Cellular Biology·L W BurrusB B Olwin
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A IsacchiM Presta
Jan 1, 1989·Annual Review of Biochemistry·W H Burgess, T Maciag
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D MoscatelliD B Rifkin
Jul 1, 1987·Journal of Cellular Physiology·R J CoffeyH L Moses
Dec 1, 1982·The Journal of Cell Biology·J L GrossD B Rifkin

❮ Previous
Next ❯

Citations

Aug 26, 2000·Cytokine & Growth Factor Reviews·B BoillyX Le Bourhis
Oct 13, 2009·The Journal of Clinical Endocrinology and Metabolism·Taneli RaivioNelly Pitteloud
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·J StratmannC A Ryan
Jul 17, 1999·European Journal of Biochemistry·J A Aguirre GhisoE B de Kier Joffè
Nov 27, 2007·Matrix Biology : Journal of the International Society for Matrix Biology·Yoshio ShimabukuroShinya Murakami
Aug 11, 2004·Developmental Biology·Jiahu Wang, Gordon W Laurie
Mar 24, 2004·Critical Reviews in Oncology/hematology·Yanusz Wegrowski, Francois-Xavier Maquart
Oct 1, 2009·Matrix Biology : Journal of the International Society for Matrix Biology·Martin D ReesMichael J Davies
Jun 24, 2006·Journal of Cellular Biochemistry·Sineenat SiriThomas T Chen
May 30, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pouya PakneshanShafaat A Rabbani
Apr 21, 1999·International Journal of Cancer. Journal International Du Cancer·R H Xing, S A Rabbani
Feb 10, 2021·Pathology, Research and Practice·Mustafa Sahin, Erman Akkus
Nov 25, 1998·Biochemical and Biophysical Research Communications·L Van den BergheB Bugler
Jun 3, 2020·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Jin-Ho ChoiHan-Wook Yoo

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.